LLYEli Lilly

Health care · Pharmaceuticals · NYSE

LLY and 9 peers, year by year

The 9 Health care companies closest to LLY in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
LLY Eli Lilly	FY2025	$65.2B	+44.7%	-	-	31.7%	-	77.8%	1.54
HCA HCA Healthcare	FY2025	$75.6B	+7.1%	-	-	9.0%	10.2%	n/m	n/m
JNJ Johnson & Johnson	FY2025	$94.2B	+6.0%	67.9%	-	28.5%	20.9%	32.9%	0.61
MRK Merck & Co.	FY2025	$65.0B	+1.3%	-	-	28.1%	19.0%	34.7%	0.94
ABBV AbbVie	FY2025	$61.2B	+8.6%	-	24.6%	6.9%	29.1%	n/m	n/m
PFE Pfizer	FY2025	$62.6B	−1.6%	-	-	12.4%	14.5%	9.0%	0.75
BMY Bristol Myers Squibb	FY2025	$48.2B	−0.2%	-	-	14.6%	26.7%	38.2%	2.55
ABT Abbott Laboratories	FY2025	$44.3B	+5.7%	-	18.2%	14.7%	16.7%	12.5%	0.25
TMO Thermo Fisher Scientific	FY2025	$44.6B	+3.9%	-	17.4%	15.0%	14.1%	12.6%	0.80
AMGN Amgen	FY2025	$36.8B	+10.0%	-	24.7%	21.0%	22.0%	89.1%	6.31

Revenuepeer median $61.2B

Sales growthpeer median +5.7%

Operating marginpeer median 21.4%

AMGN 24.7%
ABBV 24.6%
ABT 18.2%
TMO 17.4%
LLY -
HCA -
JNJ -
MRK -
PFE -
BMY -

Net marginpeer median 14.7%

FCF marginpeer median 19.0%

Return on equitypeer median 32.9%

Debt / equitypeer median 0.80

AMGN 6.31
BMY 2.55
LLY 1.54
MRK 0.94
TMO 0.80
PFE 0.75
JNJ 0.61
ABT 0.25
HCA n/m
ABBV n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	$21.2B	$20.0B	$21.5B	$22.3B	$24.5B	$28.3B	$28.5B	$34.1B	$45.0B	$65.2B
HCA Dec	$41.5B	$43.6B	$46.7B	$51.3B	$51.5B	$58.8B	$60.2B	$65.0B	$70.6B	$75.6B
JNJ Dec	$71.9B	$76.5B	$81.6B	$82.1B	-	$78.7B	$80.0B	$85.2B	$88.8B	$94.2B
MRK Dec	$39.8B	$40.1B	$42.3B	$39.1B	$41.5B	$48.7B	$59.3B	$60.1B	$64.2B	$65.0B
ABBV Dec	$25.6B	$28.2B	$32.8B	$33.3B	$45.8B	$56.2B	$58.1B	$54.3B	$56.3B	$61.2B
PFE Dec	$52.8B	$52.5B	$40.8B	$40.9B	$41.7B	$81.3B	$101.2B	$59.6B	$63.6B	$62.6B
BMY Dec	$19.4B	$20.8B	$22.6B	$26.1B	$42.5B	$46.4B	$46.2B	$45.0B	$48.3B	$48.2B
ABT Dec	$20.9B	$27.4B	$30.6B	$31.9B	$34.6B	$43.1B	$43.7B	$40.1B	$42.0B	$44.3B
TMO Dec	$18.3B	$20.9B	$24.4B	$25.5B	$32.2B	$39.2B	$44.9B	$42.9B	$42.9B	$44.6B
AMGN Dec	$23.0B	$22.8B	$23.7B	$23.4B	$25.4B	$26.0B	$26.3B	$28.2B	$33.4B	$36.8B
Peer median	$25.6B	$28.2B	$32.8B	$33.3B	$41.6B	$48.7B	$58.1B	$54.3B	$56.3B	$61.2B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	+6.3%	+7.8%	+7.6%	+3.8%	+9.9%	+15.4%	+0.8%	+19.6%	+32.0%	+44.7%
HCA Dec	-	+5.1%	+7.0%	+10.0%	+0.4%	+14.0%	+2.5%	+7.9%	+8.7%	+7.1%
JNJ Dec	-	+6.3%	+6.7%	+0.6%	-	+13.6%	+1.6%	+6.5%	+4.3%	+6.0%
MRK Dec	-	+0.8%	+5.4%	+10.7%	+6.1%	+17.3%	+21.7%	+1.4%	+6.7%	+1.3%
ABBV Dec	+12.2%	+10.1%	+16.1%	+1.6%	+37.7%	+22.7%	+3.3%	−6.4%	+3.7%	+8.6%
PFE Dec	-	−0.5%	+2.1%	+0.8%	+1.8%	+95.2%	+24.7%	−41.1%	+6.8%	−1.6%
BMY Dec	+17.3%	+6.9%	+8.6%	+15.9%	+62.6%	+9.1%	−0.5%	−2.5%	+7.3%	−0.2%
ABT Dec	+2.2%	+31.3%	+11.6%	+4.3%	+8.5%	+24.5%	+1.3%	−8.1%	+4.6%	+5.7%
TMO Dec	+7.7%	+14.5%	+16.4%	+4.9%	+26.1%	+21.7%	+14.5%	−4.6%	+0.1%	+3.9%
AMGN Dec	+6.1%	−0.6%	+3.9%	−1.6%	+8.8%	+2.2%	+1.3%	+7.1%	+18.6%	+10.0%
Peer median	+7.7%	+6.3%	+7.0%	+4.3%	+8.7%	+17.3%	+2.5%	−2.5%	+6.7%	+5.7%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
JNJ Dec	69.7%	66.7%	66.8%	66.4%	-	70.3%	69.3%	68.8%	69.1%	67.9%
MRK Dec	-	-	-	-	-	-	-	-	-	-
ABBV Dec	-	-	-	-	-	-	-	-	-	-
PFE Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	74.5%	70.7%	71.3%	69.1%	72.3%	-	-	-	-	-
ABT Dec	-	-	-	-	-	-	-	-	-	-
TMO Dec	-	-	-	-	-	-	-	-	-	-
AMGN Dec	-	-	-	-	-	-	-	-	-	-
Peer median	-	-	-	-	-	-	-	-	-	-

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
JNJ Dec	-	-	-	-	-	-	-	-	-	-
MRK Dec	-	-	-	-	-	-	-	-	-	-
ABBV Dec	36.4%	33.8%	19.5%	39.0%	24.8%	31.9%	31.2%	23.5%	16.2%	24.6%
PFE Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	-	-	-	-	-	-	-	-	-	-
ABT Dec	14.5%	5.7%	11.9%	14.2%	15.5%	19.6%	19.2%	16.2%	16.3%	18.2%
TMO Dec	13.5%	14.2%	15.5%	18.0%	24.2%	25.6%	18.7%	16.0%	17.1%	17.4%
AMGN Dec	42.6%	43.6%	43.2%	41.4%	35.9%	29.4%	36.3%	28.0%	21.7%	24.7%
Peer median	25.5%	24.0%	17.5%	28.5%	24.5%	27.5%	25.2%	19.8%	16.7%	21.4%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	12.9%	−1.0%	15.0%	37.3%	25.2%	19.7%	21.9%	15.4%	23.5%	31.7%
HCA Dec	7.0%	5.1%	8.1%	6.8%	7.3%	11.8%	9.4%	8.1%	8.2%	9.0%
JNJ Dec	23.0%	1.7%	18.8%	18.4%	-	26.5%	22.4%	41.3%	15.8%	28.5%
MRK Dec	9.8%	6.0%	14.7%	25.2%	17.0%	26.8%	24.5%	0.6%	26.7%	28.1%
ABBV Dec	23.2%	18.8%	17.4%	23.7%	10.1%	20.5%	20.4%	9.0%	7.6%	6.9%
PFE Dec	13.7%	40.6%	27.3%	39.2%	22.0%	27.0%	31.0%	3.6%	12.6%	12.4%
BMY Dec	22.9%	4.8%	21.8%	13.2%	−21.2%	15.1%	13.7%	17.8%	−18.5%	14.6%
ABT Dec	6.7%	1.7%	7.7%	11.6%	13.0%	16.4%	15.9%	14.3%	31.9%	14.7%
TMO Dec	11.1%	10.6%	12.1%	14.5%	19.8%	19.7%	15.5%	14.0%	14.8%	15.0%
AMGN Dec	33.6%	8.7%	35.3%	33.6%	28.6%	22.7%	24.9%	23.8%	12.2%	21.0%
Peer median	13.7%	6.0%	17.4%	18.4%	15.0%	20.5%	20.4%	14.0%	12.6%	14.7%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	$2.9B	$2.4B	$3.2B	$3.4B	$6.4B	$5.4B	$4.1B	$4.7B	$5.6B	$7.7B
JNJ Dec	$15.5B	$17.8B	$18.5B	$19.9B	-	$19.8B	$17.2B	$18.2B	$19.8B	$19.7B
MRK Dec	$8.8B	$4.6B	$8.3B	$10.1B	$5.8B	$8.7B	$14.7B	$9.1B	$18.1B	$12.4B
ABBV Dec	$6.6B	$9.4B	$12.8B	$12.8B	$16.8B	$22.0B	$24.2B	$22.1B	$17.8B	$17.8B
PFE Dec	$14.4B	$14.8B	$13.8B	$10.5B	$12.2B	$29.9B	$26.0B	$4.8B	$9.8B	$9.1B
BMY Dec	$1.8B	$4.2B	$6.1B	$7.4B	$13.3B	$15.2B	$11.9B	$12.7B	$13.9B	$12.8B
ABT Dec	$2.1B	$4.4B	$4.9B	$4.5B	$5.7B	$8.6B	$7.8B	$5.1B	$6.4B	$7.4B
TMO Dec	$2.8B	$3.5B	$3.8B	$4.0B	$6.8B	$6.8B	$6.9B	$6.9B	$7.3B	$6.3B
AMGN Dec	$9.6B	$10.5B	$10.6B	$8.5B	$9.9B	$8.4B	$8.8B	$7.4B	$10.4B	$8.1B
Peer median	$6.6B	$4.6B	$8.3B	$8.5B	$8.4B	$8.7B	$11.9B	$7.4B	$10.4B	$9.1B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	7.0%	5.5%	6.8%	6.7%	12.4%	9.2%	6.9%	7.2%	8.0%	10.2%
JNJ Dec	21.6%	23.3%	22.7%	24.3%	-	25.1%	21.5%	21.4%	22.3%	20.9%
MRK Dec	22.0%	11.4%	19.6%	25.7%	14.0%	17.8%	24.8%	15.2%	28.2%	19.0%
ABBV Dec	25.6%	33.4%	39.0%	38.4%	36.7%	39.1%	41.8%	40.6%	31.7%	29.1%
PFE Dec	27.2%	28.3%	33.9%	25.8%	29.2%	36.7%	25.7%	8.0%	15.5%	14.5%
BMY Dec	9.5%	20.3%	27.1%	28.2%	31.3%	32.8%	25.9%	28.1%	28.9%	26.7%
ABT Dec	10.0%	16.2%	16.0%	14.1%	16.5%	20.1%	17.9%	12.6%	15.1%	16.7%
TMO Dec	15.4%	16.7%	15.5%	15.8%	21.2%	17.3%	15.4%	16.2%	16.9%	14.1%
AMGN Dec	41.8%	46.0%	44.5%	36.5%	38.9%	32.3%	33.4%	26.1%	31.1%	22.0%
Peer median	21.6%	20.3%	22.7%	25.7%	25.2%	25.1%	24.8%	16.2%	22.3%	19.0%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	19.5%	−1.8%	32.9%	n/m	109.8%	62.2%	58.6%	48.6%	74.2%	77.8%
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
JNJ Dec	23.5%	2.2%	25.6%	25.4%	-	28.2%	23.4%	51.1%	19.7%	32.9%
MRK Dec	9.8%	7.0%	23.3%	38.0%	27.9%	34.2%	31.6%	1.0%	37.0%	34.7%
ABBV Dec	128.4%	104.2%	n/m	n/m	35.3%	74.9%	68.6%	46.9%	128.7%	n/m
PFE Dec	12.1%	29.9%	17.6%	25.4%	14.5%	28.5%	32.8%	2.4%	9.1%	9.0%
BMY Dec	27.6%	8.6%	35.1%	6.7%	−23.8%	19.5%	20.4%	27.3%	−54.8%	38.2%
ABT Dec	6.8%	1.5%	7.8%	11.9%	13.7%	19.8%	18.9%	14.8%	28.1%	12.5%
TMO Dec	9.4%	8.8%	10.7%	12.5%	18.5%	18.9%	15.8%	12.8%	12.8%	12.6%
AMGN Dec	25.8%	7.8%	67.2%	81.1%	77.2%	88.0%	179.0%	107.8%	69.6%	89.1%
Peer median	17.8%	8.2%	23.3%	25.4%	18.5%	28.3%	27.5%	21.0%	23.9%	32.9%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	0.74	1.09	0.99	5.80	2.90	1.86	1.53	2.35	2.37	1.54
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
JNJ Dec	0.41	0.60	0.55	0.47	-	0.48	0.54	0.45	0.54	0.61
MRK Dec	0.62	0.71	0.94	1.02	1.26	0.87	0.67	0.93	0.80	0.94
ABBV Dec	7.95	7.33	n/m	n/m	6.50	4.93	3.66	5.72	n/m	n/m
PFE Dec	0.62	0.61	0.64	0.81	0.07	0.49	0.37	0.81	0.72	0.75
BMY Dec	0.41	0.62	0.49	0.96	1.39	1.37	1.39	1.34	3.15	2.55
ABT Dec	1.07	0.90	0.64	0.58	0.57	0.50	0.46	0.38	0.30	0.25
TMO Dec	0.76	0.78	0.71	0.62	0.71	0.91	0.91	0.82	0.67	0.80
AMGN Dec	1.16	1.40	2.71	3.09	3.51	4.97	10.64	10.37	10.23	6.31
Peer median	0.69	0.75	0.64	0.81	1.26	0.89	0.79	0.88	0.72	0.80

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
LLY Dec	$2.58	−$0.19	$3.13	$8.89	$6.79	$6.12	$6.90	$5.80	$11.71	$22.95
HCA Dec	$7.30	$5.95	$10.66	$10.07	$10.93	$21.16	$19.15	$18.97	$22.00	$28.33
JNJ Dec	$5.93	$0.47	$5.61	$5.63	-	$7.81	$6.73	$13.72	$5.79	$11.03
MRK Dec	$1.41	$0.87	$2.32	$3.81	$2.78	$5.14	$5.71	$0.14	$6.74	$7.28
ABBV Dec	$3.63	$3.30	$3.66	$5.28	$2.72	$6.45	$6.63	$2.72	$2.39	$2.36
PFE Dec	$1.17	$3.52	$1.87	$2.82	$1.63	$3.85	$5.47	$0.37	$1.41	$1.36
BMY Dec	$2.65	$0.61	$3.01	$2.01	−$3.99	$3.12	$2.95	$3.86	−$4.41	$3.46
ABT Dec	$0.94	$0.27	$1.33	$2.06	$2.50	$3.94	$3.91	$3.26	$7.64	$3.72
TMO Dec	$5.09	$5.59	$7.24	$9.17	$15.96	$19.46	$17.63	$15.45	$16.53	$17.74
AMGN Dec	$10.24	$2.69	$12.62	$12.88	$12.31	$10.28	$12.11	$12.49	$7.56	$14.23
Peer median	$3.63	$2.69	$3.66	$5.28	$2.75	$6.45	$6.63	$3.86	$6.74	$7.28

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out LLY and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on LLY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LLY/export.csv") into a cell.